DJ-1 Protects Breast Cancer Cells Against 2′-Benzoyloxycinnamaldehyde-induced Oxidative Stress Independent of Nrf2

Journal of Cellular Physiology

Volumn 230, Issue 9, 2015, Pages 2262-2269

  Ismail, Ismail Ahmed ^a,b   Abdel shakor, Abo bakr ^b,c   Hong, Su Hyung ^d  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b Assiut University   (Egypt)

^c KING KHALID UNIVERSITY   (Saudi Arabia)

^d Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2' BENZOYLOXYCINNAMALDEHYDE; ANTINEOPLASTIC AGENT; DJ 1 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; 2'-BENZOYLOXYCINNAMALDEHYDE; ACROLEIN; BENZOIC ACID DERIVATIVE; NFE2L2 PROTEIN, HUMAN; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; BREAST CANCER; CANCER CELL LINE; CELL FRACTIONATION; CELL PROTECTION; CELL VIABILITY; CELL VIABILITY ASSAY; CINNAMOMUM CASSIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MCF 7 CELL LINE; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRANSFORMED CELL; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; BREAST NEOPLASMS; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MITOCHONDRION; PATHOLOGY; SIGNAL TRANSDUCTION;

ACROLEIN; BENZOATES; BREAST NEOPLASMS; CYTOPROTECTION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MCF-7 CELLS; MITOCHONDRIA; NF-E2-RELATED FACTOR 2; ONCOGENE PROTEINS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84929833783     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24957     Document Type: Article

References (40)

1. Aleyasin H, Rousseaux MW, Marcogliese PC, Hewitt SJ, Irrcher I, Joselin AP, Parsanejad M, Kim RH, Rizzu P, Callaghan SM, Slack RS, Mak TW, Park DS. 2010. DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad Sci USA 107:3186-3191.
2. Chen JS, Agarwal N, Mehta K. 2002. Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools. Breast Cancer Res Treat 71:237-247.
3. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP. 2006. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 103:15091-15096.
4. Cookson MR. 2003. Pathways to Parkinsonism. Neuron 37:7-10.
5. Fan J, Ren H, Fei E, Jia N, Ying Z, Jiang P, Wu M, Wang G. 2008a. Sumoylation is critical for DJ-1 to repress p53 transcriptional activity. FEBS Lett 582:1151-1156.
6. Fan J, Ren H, Jia N, Fei E, Zhou T, Jiang P, Wu M, Wang G. 2008b. DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem 283:4022-4030.
7. Gan L, Johnson DA, Johnson JA. 2010. Keap1-Nrf2 activation in the presence and absence of DJ-1. Eur J Neurosci 31:967-977.
8. Gu L, Cui T, Fan C, Zhao H, Zhao C, Lu L, Yang H. 2009. Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress. Biochem Biophys Res Commun 383:469-474.
9. Han DC, Lee MY, Shin KD, Jeon SB, Kim JM, Son KH, Kim HC, Kim HM, Kwon BM. 2004. 2′-Benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species. J Biol Chem 279:6911-6920.
10. Hong SH, Kim J, Kim JM, Lee SY, Shin DS, Son KH, Han DC, Sung YK, Kwon BM. 2007. Apoptosis induction of 2′-hydroxycinnamaldehyde as a proteasome inhibitor is associated with ER stress and mitochondrial perturbation in cancer cells. Biochem Pharmacol 74:557-565.
11. Inberg A, Linial M. 2010. Protection of pancreatic {beta}-cells from various stress conditions is mediated by DJ-1. J Biol Chem 285:25686-25698.
12. Ismail IA, Kang HS, Lee HJ, Chang H, Yun J, Lee CW, Kim NH, Kim HS, Yook JI, Hong SH, Kwon BM. 2013. 2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells. Breast Cancer Res Treat 137:697-708.
13. Ismail IA, Kang HS, Lee HJ, Kwon BM, Hong SH. 2012. 2′-Benzoyloxycinnamaldehyde-mediated DJ-1 upregulation protects MCF-7 cells from mitochondrial damage. Biol Pharm Bull 35:895-902.
14. Junn E, Jang WH, Zhao X, Jeong BS, Mouradian MM. 2009. Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J Neurosci Res 87:123-129.
15. Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, Mouradian MM. 2005. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA 102:9691-9696.
16. Kaspar JW, Niture SK, Jaiswal AK. 2009. Nrf2: INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47:1304-1309.
17. Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, DeLuca C, Liepa J, Zhou L, Snow B, Binari RC, Manoukian AS, Bray MR, Liu FF, Tsao MS, Mak TW. 2005. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7:263-273.
18. Kim YC, Kitaura H, Taira T, Iguchi-Ariga SM, Ariga H. 2009. Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. Int J Oncol 35:1331-1341.
19. Kwon B, Lee SH, Cho YK, Bok SH, So SH, Youn MR, Chang SI. 1997. Synthesis and biological activity of cinnamaldehydes as anbiogenesis inhibitors. Bioorg Med Chem Lett 7:2473-2476.
20. Kwon BM, Cho YK, Lee SH, Nam JY, Bok SH, Chun SK, Kim JA, Lee IR. 1996. 2′-Hydroxycinnamaldehyde from stem bark of Cinnamomum cassia. Planta Med 62:183-184.
21. Lev N, Ickowicz D, Barhum Y, Lev S, Melamed E, Offen D. 2009a. DJ-1 protects against dopamine toxicity. J Neural Transm 116:151-160.
22. Lev N, Ickowicz D, Barhum Y, Melamed E, Offen D. 2009b. DJ-1 changes in G93A-SOD1 transgenic mice: Implications for oxidative stress in ALS. J Mol Neurosci 38:94-102.
23. Liu H, Wang M, Li M, Wang D, Rao Q, Wang Y, Xu Z, Wang J. 2008. Expression and role of DJ-1 in leukemia. Biochem Biophys Res Commun 375:477-483.
24. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
25. Loignon M, Miao W, Hu L, Bier A, Bismar TA, Scrivens PJ, Mann K, Basik M, Bouchard A, Fiset PO, Batist Z, Batist G. 2009. Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy. Mol Cancer Ther 8:2432-2440.
26. MacKeigan JP, Clements CM, Lich JD, Pope RM, Hod Y, Ting JP. 2003. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: Identification of RS/DJ-1 and RhoGDIalpha. Cancer Res 63:6928-6934.
27. Malhotra D, Thimmulappa R, Navas-Acien A, Sandford A, Elliott M, Singh A, Chen L, Zhuang X, Hogg J, Pare P, Tuder RM, Biswal S. 2008. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 178:592-604.
28. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H. 1997. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231:509-513.
29. Niture SK, Kaspar JW, Shen J, Jaiswal AK. 2010. Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 244:37-42.
30. Ock J, Lee HA, Ismail IA, Lee HJ, Kwon BM, Suk K, Lee WH, Hong SH. 2011. Differential antiproliferation effect of 2′-benzoyloxycinnamaldehyde in K-ras-transformed cells via downregulation of thiol antioxidants. Cancer Sci 102:212-218.
31. Rojo AI, Sagarra MR, Cuadrado A. 2008. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: Relevance to exposure of neuronal cells to oxidative stress. J Neurochem 105:192-202.
32. Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A. 2006. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 281:14841-14851.
33. Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A. 2004. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2:e362.
34. Shinbo Y, Taira T, Niki T, Iguchi-Ariga SM, Ariga H. 2005. DJ-1 restores p53 transcription activity inhibited by Topors/p53 BP3. Int J Oncol 26:641-648.
35. Sitaram RT, Cairney CJ, Grabowski P, Keith WN, Hallberg B, Ljungberg B, Roos G. 2009. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma. Int J Cancer 125:783-790.
36. Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak GT, Wong PK, Zhang DD. 2008. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235-1243.
37. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, Mizusawa H. 2003. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 312:1342-1348.
38. Zhang D, Lim SG, Koay ES. 2007. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma. Int J Oncol 31:577-584.
39. Zhou W, Freed CR. 2005. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J Biol Chem 280:43150-43158.
40. Zobalova R, Swettenham E, Chladova J, Dong LF, Neuzil J. 2008. Daxx inhibits stress-induced apoptosis in cardiac myocytes. Redox Rep 13:263-270.